CN110845516B - Synthetic method of penicillin G sulfoxide diphenylmethyl ester - Google Patents

Synthetic method of penicillin G sulfoxide diphenylmethyl ester Download PDF

Info

Publication number
CN110845516B
CN110845516B CN201911082524.9A CN201911082524A CN110845516B CN 110845516 B CN110845516 B CN 110845516B CN 201911082524 A CN201911082524 A CN 201911082524A CN 110845516 B CN110845516 B CN 110845516B
Authority
CN
China
Prior art keywords
penicillin
compound
synthesis
reaction
sulfoxide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201911082524.9A
Other languages
Chinese (zh)
Other versions
CN110845516A (en
Inventor
邱国华
陈迪才
汪前胜
王红萍
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yancheng Kaiyuan Medicine Chemistry Co ltd
Original Assignee
Yancheng Kaiyuan Medicine Chemistry Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yancheng Kaiyuan Medicine Chemistry Co ltd filed Critical Yancheng Kaiyuan Medicine Chemistry Co ltd
Priority to CN201911082524.9A priority Critical patent/CN110845516B/en
Publication of CN110845516A publication Critical patent/CN110845516A/en
Application granted granted Critical
Publication of CN110845516B publication Critical patent/CN110845516B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/21Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/44Compounds with an amino radical acylated by carboxylic acids, attached in position 6
    • C07D499/46Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with acyclic hydrocarbon radicals or such radicals substituted by carbocyclic or heterocyclic rings, attached to the carboxamido radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/04Preparation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention discloses a synthetic method of penicillin G sulfoxide diphenylmethyl ester. Taking penicillin G sylvite as a starting material, esterifying the penicillin G sylvite, and then performing esterification on the penicillin G sylvite by using 2KHSO5·KHSO4·K2SO4The penicillin G sulfoxide diphenylmethyl ester is synthesized by oxidation, the product purity is over 99 percent, the total molar yield is over 95 percent, and the method is suitable for industrial production. The invention has the advantages of easily obtained raw materials, high yield, less pollution, high safety factor, easy operation and the like.

Description

Synthetic method of penicillin G sulfoxide diphenylmethyl ester
Technical Field
The invention belongs to the field of synthesis of small molecular compounds, and relates to a synthesis method of penicillin G sulfoxide diphenylmethyl ester.
Background
Cephalosporin is an important antibiotic, and has the characteristics of strong antibacterial action, good curative effect, low toxicity, broad spectrum and penicillinase resistance. Therefore, the compound has wide development prospect as a first-line medicament in clinic. At present, cephalosporin and intermediates thereof such as 7-AVCA, 7-ACCA, 7-ANCA, 7-AMCA and the like are mainly prepared from 7-ACA and penicillin. However, due to the high cost of 7-ACA as a raw material [1], many people have looked at the wider source of relatively inexpensive penicillin raw material. The penicillin G sulfoxide diphenyl methyl ester is used as an important intermediate for synthesizing cephalosporin through expansion ring, and the research on the synthesis process of the penicillin G sulfoxide diphenyl methyl ester is particularly important.
Penicillin G sulfoxide diphenylmethyl ester is an important intermediate of a mother nucleus of cephalosporin antibiotics, and the molecular formula of the penicillin G sulfoxide diphenylmethyl ester is as follows: c29H28N2O5S, molecular weight 516.61, white or off-white powder in appearance, structural formula as follows:
Figure BDA0002264396700000011
the process for preparing penicillin sulfoxide esters from penicillin G potassium salt can be generally divided into two processes of esterification and oxidation, and esterification. Zhang Xiaofeng et al reported a synthesis method of penicillin G sulfoxide diphenyl methyl ester, which uses penicillin G potassium (3) as raw material, uses 18% peroxyacetic acid to oxidize it to obtain penicillin G sulfoxide acid (2), and uses diphenyl methanol to esterify it with dichloromethane solution to obtain penicillin G sulfoxide diphenyl methyl ester (1). However, the total yield of the method is only 77.35% (Zhang Xiaofeng, Zhongjing, Zhang hui Liang. synthesis research of penicillin G sulfoxide diphenylmethyl ester [ J ] fine chemical intermediate, 2008,38(4): 34-37).
At present, the process of penicillin G sulfoxide diphenyl methyl ester oxidation process is mainly researched in two aspects, one is that a peroxyacetic acid method is adopted, the method is high in yield, but generates a large amount of acidic wastewater and causes serious pollution, and peroxyacetic acid synthesis belongs to a high-risk process, is flammable, has the characteristics of explosiveness, strong corrosivity, strong irritation and the like, is not beneficial to operation and is low in safety factor; secondly, the method adopts the oxidation method of hydrogen peroxide and supported catalyst, and the yield of the method is low.
In conclusion, under the current situation of safety and increasingly severe environmental protection, the synthesis of penicillin G sulfoxide diphenyl methyl ester is necessary to develop an oxidation process which has high yield, is safe and environment-friendly, is easy to operate and is suitable for industrial production aiming at the defects of the prior art.
Disclosure of Invention
The invention aims to provide a method for synthesizing penicillin G sulfoxide diphenylmethyl ester, which has high yield, safety and environmental protection aiming at the defects in the prior art.
The purpose of the invention can be realized by the following technical scheme:
a synthetic method of penicillin G sulfoxide diphenylmethyl ester is characterized in that a compound 2 is oxidized by hydrogen sulfate methyl complex salt to obtain penicillin G sulfoxide diphenylmethyl ester, and the reaction route is as follows:
Figure BDA0002264396700000021
said compound 2 is preferably synthesized by the following route:
Figure BDA0002264396700000022
the synthesis of the penicillin G sulfoxide diphenylmethyl ester further preferably comprises the following steps in sequence:
using a compound 1 as a raw material, and performing esterification to obtain a compound 2:
Figure BDA0002264396700000023
oxidizing the hydrogen persulfate complex salt in the step (b) to obtain a compound 3:
Figure BDA0002264396700000031
the oxidation reaction is preferably 2KHSO5·KHSO4·K2SO4Dissolving in 2KHSO5·KHSO4·K2SO44 times of the weight of the compound 1 and 2KHSO5·KHSO4·K2SO4The molar ratio of (A) to (B) is 1: 0.6-0.8.
The oxidation reaction temperature is preferably 20-30 ℃, further preferably 20-25 ℃, and the reaction time is preferably 5-6 h.
In the esterification reaction of step (a), the reaction solvent is preferably methyl halide or ethyl halide, more preferably methyl chloride or ethyl chloride, and preferably methylene chloride.
In the esterification reaction in the step (a), the molar ratio of the compound 1 to the benzhydrol, the pyridine and the methylsulfonyl chloride is preferably 1: 1.0-1.2: 1.5-2.0: 1.1-1.4.
(a) The esterification reaction temperature is preferably 0-20 ℃, and further preferably 10-15 ℃; the reaction time is preferably 4-5 h.
Has the advantages that:
the invention takes the potassium salt of penicillin as the starting material, and penicillin G sulfoxide diphenylmethyl ester is synthesized by two steps, the product purity is more than 99 percent, the total molar yield is more than 95 percent, and the invention is suitable for industrial production. The method has the advantages of easily available raw materials, high yield, less pollution, high safety coefficient, easy operation and the like. In the oxidation step the invention uses persulfurAcid hydrogen methyl composite salt (2 KHSO)5·KHSO4·K2SO4) The hydrogen persulfate-methyl persulfate composite salt is used as the oxidizing agent, has very strong and effective non-chlorine oxidation capability, meets the requirements of safety and environmental protection in the use and treatment process, avoids the problem of environmental pollution caused by using peroxyacetic acid by using the hydrogen persulfate-methyl persulfate composite salt as the oxidizing agent, and obviously improves the yield compared with the oxidation method of hydrogen peroxide and a supported catalyst.
Detailed Description
The present disclosure is further illustrated or described below by examples, which should not be construed as limiting the scope of the present disclosure.
Example 1
(1) Synthesis of Compound 2:
adding 120ml of dichloromethane, benzhydrol (23.2g, 0.126mol) and compound 1(40g, 0.107mol) into a 500ml four-neck flask, cooling to 15 ℃, adding pyridine (16g, 0.202mol), dropwise adding methylsulfonyl chloride (16g, 0.140mol) at the temperature of 10-15 ℃, controlling the dropwise addition to be finished for 60min, and preserving the heat for 4 hours after the dropwise addition is finished. After the completion of the incubation, 135g of 5% dilute sulfuric acid was added and the mixture was washed, the organic phase was separated, the aqueous phase was extracted with 30ml of dichloromethane, the organic phases were combined to obtain a dichloromethane solution of Compound 2, and the solution was transferred to a 1000ml four-necked flask for use.
(2) Synthesis of Compound 3:
the dichloromethane solution of the compound 2 prepared in the above step was adjusted to 22 ℃. Preparing a potassium hydrogen persulfate composite salt aqueous solution: potassium hydrogen persulfate complex salt (45g, 0.073mol) was weighed in a 500ml beaker, 160ml of water was added thereto, and dissolved by stirring. And controlling the temperature to be 20-25 ℃, dropwise adding the prepared potassium hydrogen persulfate composite salt aqueous solution into the reaction solution, and controlling the dripping for 60 min. After dripping, the temperature is kept for 6 hours. Layering, separating an organic phase, performing vacuum distillation on the organic phase, adding 350ml of prepared methanol after dichloromethane is evaporated to dryness, cooling to 0 ℃ for crystallization, performing suction filtration, and performing vacuum drying on a wet product at 50-60 ℃ for 4.5h to obtain 53.1g of a compound 3, wherein the molar yield is 95.7%, and the HPLC purity is 99.54%.
The above description is only an embodiment of the present invention, and not intended to limit the scope of the present invention, and all modifications of equivalent structures and equivalent processes, which are made by the present specification, or directly or indirectly applied to other related technical fields, are included in the scope of the present invention.

Claims (12)

1. A synthetic method of penicillin G sulfoxide diphenylmethyl ester is characterized in that a compound 2 is oxidized by hydrogen sulfate methyl complex salt to obtain penicillin G sulfoxide diphenylmethyl ester, and the reaction route is as follows:
Figure FDA0003522771050000011
2. the synthesis according to claim 1, characterized in that said compound 2 is synthesized by the following route:
Figure FDA0003522771050000012
3. a synthesis process according to claim 1 or 2, characterized in that the synthesis of penicillin G sulfoxide benzhydryl ester comprises the following steps in sequence:
using a compound 1 as a raw material, and performing esterification to obtain a compound 2:
Figure FDA0003522771050000013
oxidizing the hydrogen persulfate complex salt in the step (b) to obtain a compound 3:
Figure DEST_PATH_FDA0002264396690000014
4. the synthesis method according to claim 1, wherein the oxidation reaction uses 2KHSO5·KHSO4·K2SO4Dissolving in 2KHSO5·KHSO4·K2SO44 times of the weight of the compound 1 and 2KHSO5·KHSO4·K2SO4The molar ratio of (A) to (B) is 1: 0.6-0.8.
5. The synthesis method according to claim 1, wherein the oxidation reaction temperature is 20-30 ℃ and the reaction time is 5-6 h.
6. The synthesis method according to claim 5, wherein the oxidation reaction temperature is 20-25 ℃.
7. The synthesis process according to claim 3, wherein in the esterification reaction of step (a), the reaction solvent is methyl halide or ethyl halide.
8. The synthesis process according to claim 3, wherein in the esterification reaction of step (a), the reaction solvent is methyl chloride or ethyl chloride.
9. The method of claim 8, wherein the esterification reaction of step (a) is carried out in the presence of methylene chloride as a reaction solvent.
10. The synthesis method according to claim 3, wherein in the esterification reaction in step (a), the molar ratio of the compound 1 to the benzhydrol, the pyridine and the methylsulfonyl chloride is 1: 1.0-1.2: 1.5-2.0: 1.1-1.4.
11. The synthesis method according to claim 3, wherein the esterification reaction temperature in step (a) is 0-20 ℃ and the reaction time is 4-5 h.
12. The synthesis method according to claim 3, wherein the esterification reaction temperature in the step (a) is 10-15 ℃.
CN201911082524.9A 2019-11-07 2019-11-07 Synthetic method of penicillin G sulfoxide diphenylmethyl ester Active CN110845516B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201911082524.9A CN110845516B (en) 2019-11-07 2019-11-07 Synthetic method of penicillin G sulfoxide diphenylmethyl ester

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201911082524.9A CN110845516B (en) 2019-11-07 2019-11-07 Synthetic method of penicillin G sulfoxide diphenylmethyl ester

Publications (2)

Publication Number Publication Date
CN110845516A CN110845516A (en) 2020-02-28
CN110845516B true CN110845516B (en) 2022-06-21

Family

ID=69598588

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201911082524.9A Active CN110845516B (en) 2019-11-07 2019-11-07 Synthetic method of penicillin G sulfoxide diphenylmethyl ester

Country Status (1)

Country Link
CN (1) CN110845516B (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101070315A (en) * 2007-05-11 2007-11-14 江苏工业学院 Method for preparing omeprazole
CN103497206A (en) * 2013-10-09 2014-01-08 盐城开元医药化工有限公司 Synthesis method for cefaclor key intermediate
CN107298666A (en) * 2016-04-15 2017-10-27 上海医药工业研究院 A kind of Preparation Method And Their Intermediate of flavone compound

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101070315A (en) * 2007-05-11 2007-11-14 江苏工业学院 Method for preparing omeprazole
CN103497206A (en) * 2013-10-09 2014-01-08 盐城开元医药化工有限公司 Synthesis method for cefaclor key intermediate
CN107298666A (en) * 2016-04-15 2017-10-27 上海医药工业研究院 A kind of Preparation Method And Their Intermediate of flavone compound

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Oxidation of Thymines by Peroxosulfate Ions in Water;Toshio Itahara,等;《J.Org.Chem.》;19881231;第53卷(第15期);3421-3424 *
Use of Alumina for Elimination of Sulfinic Acid from β-ARYL- ANDβ-Alkylsulfonyl Carbonyl Compounds;Joelle Vidal,等;《Tetrahedron Letters》;19861231;第27卷(第32期);3733-3736 *

Also Published As

Publication number Publication date
CN110845516A (en) 2020-02-28

Similar Documents

Publication Publication Date Title
CN109438591B (en) Preparation process of sugammadex sodium
WO2010054515A1 (en) Process for the preparation of 4-(1-hydroxy-1-methylethyl)- 2-propyl-imidazole-5-carboxylates
CN110305080A (en) A kind of purification process of docetaxel
CN110845516B (en) Synthetic method of penicillin G sulfoxide diphenylmethyl ester
CN113666946B (en) Preparation method of 2 beta-triazole methyl penicillanic acid diphenylmethyl ester, tazobactam intermediate and tazobactam
CN101768171B (en) Synthesis method of cefpodoxime proxetil compound
JP2005529082A5 (en)
MX2010009303A (en) Process for the preparation of pregnane derivatives.
CN115504947B (en) Preparation method of furanone acid
WO2023206607A1 (en) Method for preparing oxacephem parent nucleus intermediate
CN101848911A (en) Acid addition salts of synthetic intermediates for carbapenem antibiotics and processes for preparing the same
CN108070013A (en) The preparation method of 21- halogenated steroid compounds
CN112851730B (en) Synthesis method of NMN intermediate NR chloride
CN103709210B (en) The preparation technology of isopropyl-β-D-thiogalactoside
CN106905161A (en) A kind of synthetic method of the nitrobenzoic acid of 2 chlorine, 4 fluorine 5
CN113666945B (en) Preparation method of 2 beta-azido methyl penicillanic acid diphenylmethyl ester, tazobactam intermediate and tazobactam
CN108299470B (en) Preparation method of cefteram pivoxil
CN112125857A (en) Preparation method of acipimox
EP3581577B1 (en) 15-oxosteroid compound and method for producing same
CN104610277B (en) A kind of method that allylic hydroxylating prepares oxacephems antibiotic key intermediate
WO2021248763A1 (en) Method for preparing laninamivir
CN115215834B (en) Preparation method of vinyl sulfate
CN106588712A (en) Purification method capable of reducing sulfate content of p-toluenesulfonic acid
CN110467529B (en) Synthesis method of ester
WO2021248764A1 (en) Method for preparing laninamivir octanoate intermediate by means of one-pot synthesis

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant